Founded in 2020, the European Innovation Council is a Brussels-based venture capital initiative that supports top innovators, entrepreneurs, small companies, and researchers with bright ideas. It co-invests with private investors in early-stage startups, prioritizes deep technology ventures, and pursues ESG-positive impacts to accelerate commercialization and scale-up.

Ambrosia Investments is a growth equity investment firm focused on the food, beverage and ingredients sectors. Based in Geneva, Switzerland, it operates across the United States and Europe, providing minority growth capital to ambitious entrepreneurs seeking scale. The firm typically makes equity investments in the range of €2 million to €20 million per deal and emphasizes partnerships with management to accelerate product innovation, market expansion and operational scaling within the food and beverage value chain.

4See Ventures is a Swiss venture capital firm based in Geneva, founded in 2019. It invests in healthcare, biotech, medtech, technology, sustainability and climate tech ventures, primarily in Switzerland, and supports entrepreneurs who are defining the future and aiming to deliver positive societal impact.

Reuben Brothers is a Geneva, Switzerland-based family office founded in 2002, pursuing private equity and venture capital investments while excluding real estate development from its portfolio and engaging in debt financing.

Medicxi is a European life sciences investment firm formed by the former life sciences team of Index Ventures, leveraging more than two decades of drug discovery and therapeutic development experience. Headquartered in London with offices in Geneva and Jersey, the firm backs startups across the full lifecycle of biotechnology and pharmaceutical companies, from seed through growth stages, with a focus on Europe and the United States. Its investments concentrate on healthcare and life sciences, including therapeutics development in areas such as oncology, immunology, and neuroscience, aiming to advance innovative science toward clinical impact. Medicxi acts as a strategic partner, providing funding and guidance to accelerate discovery, development, and value creation for unmet medical needs.

Blufolio is a Swiss-based blockchain venture capital firm founded in 2018 and headquartered in Versoix. It invests in technology companies advancing blockchain and sustainability, including equity and token opportunities, with activities centered in Geneva and Switzerland. The firm employs a Luxembourg-registered fund structure to offer a diversified portfolio of blockchain startups to qualified investors globally, with partners such as Swisscom Blockchain, Zurich Insurance, and KPMG supporting portfolio companies.

Vinci Capital is a Swiss venture capital and private equity firm focused on mid to late venture, succession financing, owner- and management buyouts, spin-offs or carve-outs, and secondary share-backs. It invests in Swiss technology and industrial companies, typically committing CHF 7–10 million per portfolio and targeting firms with annual sales of roughly CHF 20–80 million. The firm seeks opportunities in new media technologies and services, life sciences, microelectronics and nanotechnology, and software and e-Business, and it often takes board seats and can syndicate larger rounds. Founded in 2003 and headquartered in Geneva with an office in Zug, Vinci Capital operates as a subsidiary of Vinci Partners.

Alpana Ventures is a Swiss venture capital firm focused on digital transformation and early-stage deep tech, founded in 2016 and headquartered in Geneva with offices in Paris, Saratoga (California) and Sierre. The firm supports founder teams across Switzerland, Europe and the United States, investing across seed, early stage, Series A/B and growth capital. Its scope covers healthcare, information technology, finance, enterprise solutions, mobility, social media, gaming and cybersecurity, and it emphasizes embedding portfolio companies into innovative business models to become global market leaders. Guided by ESG criteria, Alpana Ventures seeks to contribute to a more sustainable future.

Ginko Ventures is a venture capital firm founded in 2015 and based in Geneva, Switzerland. It targets technology companies across Europe and Israel, focusing on technologies, devices and solutions in connected objects, mobility, robotics, big data and artificial intelligence, with the aim of backing innovations that can rapidly reach global markets and improve how people work, play and live.

French Partners is a venture capital firm founded in 2016 and based in Geneva, Switzerland. It focuses on early-stage and growing companies led by French entrepreneurs with international expansion ambitions. The firm typically makes minority investments and participates in co-investments with qualified investors, often committing between €1 million and €5 million. It targets startups and SMEs with revenues up to tens of millions of euros seeking to accelerate their international presence.

Founded in 2019 and based in Geneva, Switzerland, Olive Capital is an angel network that provides its members access to investment opportunities in innovative, early-stage companies. Focusing primarily on the web3 sector, they leverage a deep global network of entrepreneurs to offer unique investment prospects.

Merck is a German science and technology company based in Darmstadt. Founded in 1668, it operates three main business areas: Life Science, which provides laboratory consumables and instruments for researchers; Electronics, which offers specialty materials for manufacturing semiconductors and displays; and Healthcare, which develops and sells branded pharmaceuticals with significant concentrations in oncology, neurology and fertility, supported by patient devices and digital health solutions. The company serves customers worldwide across Europe, Africa, Asia, Oceania and Latin America. Historically, the business is distinct from Merck & Co. in the United States and Canada, which operates under a different name in those markets. Merck is one of the oldest operating chemical and pharmaceutical companies.

Gimv is a European investment company established in 1980 and based in Antwerp, Belgium. It specializes in private equity and venture capital, backing companies across consumer, food, wellbeing, healthcare, life sciences, smart industries, energy, electrification, digitalisation and automation, and sustainable cities. Gimv manages investments in a diversified portfolio of companies, with around 85 portfolio companies generating more than EUR 6 billion in combined turnover and employing over 28,000 people. The firm oversees approximately EUR 1.8 billion of investments, including third-party funds. It operates across multiple European markets, including France, Germany, Belgium, the Netherlands, Luxembourg, Austria and Switzerland.

INKEF Capital is a venture capital firm based in Amsterdam, the Netherlands. It focuses on technology and healthcare, backing early-stage and Series A and growth-oriented companies across Europe. The firm pursues a patient, long-term investment approach and supports portfolio companies through multiple funding rounds as they scale. Its investments cover technology-driven sectors, including digital health, life sciences, biotechnology, enterprise software, fintech, and related fields, aiming to help entrepreneurs build successful international businesses from the Netherlands outward.

VI Partners is a Swiss venture capital firm based in Altendorf that specializes in funding healthcare, biotechnology, technology, and software companies across Switzerland and Europe. Founded in 2001, it supports high-growth startups through seed and Series A stages with capital, coaching, and networks, including involvement in university spin-offs. The firm focuses on building lasting value by pairing entrepreneurs with strategic expertise and industry insight to advance innovative companies.

Founded in 2017, DART Ventures is a Swiss venture capital firm investing in breakthrough technologies that positively impact health and climate. The company focuses on B2B, healthtech, foodtech, clean tech, and climate tech sectors across the U.S. and Europe. DART's unique approach includes a 12-month expansion program for startups, providing strategic guidance and access to experienced partners.

CDP Venture Capital is a leading venture capital fund manager in Italy and Europe with assets under management of about 4.9 billion euros. Based in Rome and founded in 2015, the firm invests directly and indirectly in innovative companies spanning AI and cybersecurity, green transition, fintech and other sectors. It supports the Italian entrepreneurial ecosystem by connecting institutions, companies, universities and research centers to foster venture capital development and knowledge sharing. The firm backs startups and growth-stage companies through multiple funds and initiatives, targeting consumer products and services, energy, healthcare, information technology, automotive, fashion, food, insurtech and related sectors in Italy. It pursues sustainable practices and meaningful partnerships to contribute to innovation and economic growth.

Omega Funds is a Boston-based venture capital firm founded in 2004 that focuses on early-stage investments in healthcare and biotech. It backs companies across biotechnology, pharmaceuticals, digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and software-as-a-service, with activity in North America and Western Europe. The firm manages multiple funds and operates as a registered investment adviser, leveraging its network to support entrepreneurs and advance innovations in medicine and related technologies.

Syncona is a London-based investment firm focused on building global leaders in life sciences. Founded in 2012, it pursues long-term investments in healthcare, with emphasis on gene and cell therapies, targeted cell therapy, advanced diagnostics, and other innovative areas. It invests across startup to established companies, typically committing between £1 million and £20 million per company and often taking either majority or syndicate positions. Syncona seeks to translate scientific advances into transformative treatments through a portfolio approach that combines capital, strategic support, and operational expertise to accelerate development of world-class life science companies.

Gaingels is a venture capital organization focused on supporting LGBTQ+ founders and leaders and their allies. It invests across stages and industries, building a global portfolio of 130+ companies and deploying around $70 million in capital. Beyond funding, Gaingels helps portfolio companies recruit diverse C-suite and board talent and fosters a global community of investors, operators, and entrepreneurs working toward inclusive leadership and positive social change through business.

Amboy Street Ventures is a venture capital firm founded in 2021 and based in Los Angeles. It targets investments in fertility, sexual health, and women’s health technology startups, supporting companies advancing health tech in the United States and Europe.

Verve Ventures is a European venture capital firm and startup investment platform founded in 2010 and based in Switzerland. It operates a fully digital platform that connects early-stage science and technology startups with a network of private and institutional investors, enabling investments from seed to later rounds and supporting portfolio companies with access to talent, client introductions, and expert networks. The portfolio spans energy, computing, robotics, quantum computing, digital health, climate technologies, data analytics, and advanced manufacturing, with a focus on transformative technologies across Europe. Verve Ventures emphasizes rigorous due diligence to identify high-potential opportunities and has built a large community of qualified private investors, family offices, pension funds, and corporates seeking access to European tech ventures. The firm positions itself as a bridge between founders seeking capital and investors seeking exposure to top-tier European startups, aiming to broaden access to otherwise intransparent venture opportunities.

OCCIDENT is an owner-managed venture capital firm that invests in deep tech start-ups, focusing on spin-offs from scientific research to enable real-world solutions. With offices in Munich and Zug, it supports early-stage companies in life sciences and industrial tech, and accompanies portfolio companies over the long term with financial backing and extensive operating experience. The firm invests its own money and makes decisions based on sustainable potential for success, aiming to contribute positively to society in a sustainable way. OCCIDENT collaborates closely with founding teams to tackle challenges, foster innovation, and drive long-term impact.

LIFTT is a venture capital firm and holding company focused on deep tech investments across Europe. The firm operates with a multi-vertical strategy spanning health, energy, data, critical resources, infrastructure for the data revolution, and industrial automation. Founded in 2019 and headquartered in Turin, Italy, LIFTT seeks to accelerate the transition of scientific research into commercially impactful businesses by connecting ideas, talent, and resources. It supports portfolio companies across sectors and has invested in ventures such as Wearable Robotics and Vitrealab, reflecting its emphasis on technologies with real-world applications and scalable impact.

Panakes Partners is an independent venture capital firm based in Milan, Italy, that focuses on early-stage investments in life sciences and healthcare companies across Europe and Israel. It provides capital and hands-on support to entrepreneurs and scientific teams, leveraging a network of clinicians and industry experts to help portfolio companies advance products and reach clinical and commercial milestones. The firm’s activity spans dermatology, oncology, cardiovascular disease, and neurology, and it emphasizes sustainable impact through ESG principles and adherence to broader European innovation programs.

Mayo Clinic is a non-profit medical organization based in Rochester, Minnesota, established in 1864. It provides medical care across a wide range of specialties, supports education in clinical medicine and the medical sciences, and conducts extensive medical research through programs nationwide. The organization operates as a physician-led group practice and maintains entities such as Mayo Clinic Ventures, which translates inventions into patient care and educational and research initiatives, and Mayo Clinic Platform, an accelerator and incubator focused on health technology and artificial intelligence startups.

Spicehaus Partners is an independent Swiss venture capital firm based in Zug that backs early-stage technology companies in Switzerland, with an emphasis on B2B technology firms; founded in 2018 and owned by its partners, the firm combines investment experience with entrepreneurial expertise and actively supports its portfolio companies to promote growth, aiming to foster long-term partnerships between entrepreneurs and investors.

NEXT VENTŪRES is a venture capital firm founded in 2018 and located in Austin, Texas. The firm specializes in investments within the sports, fitness, nutrition, and wellness sectors. With a team that possesses extensive expertise and strong industry connections, NEXT VENTŪRES is equipped to generate substantial value for both its investors and portfolio companies.

ACE & Company is a private equity and venture capital firm established in 2005 and based in Geneva, Switzerland, with offices in London, Cairo, Hong Kong and New York. The firm invests globally across private markets and engages in angel, growth, early, mature, buyout and secondary transactions, often taking leading or co-investment roles at multiple stages. It maintains a sector- and region-agnostic approach while pursuing opportunities in healthcare services, information technology, financial services, energy services, business products and services, as well as consumer goods and technology. ACE emphasizes diversified portfolios and risk management by sizing investments to the risk profile and tailoring exposure to a company’s development stage, seeking long-term, sustainable returns. Through specialized investment teams, it aims to provide flexible, long-term capital and strategic support to portfolio companies across its global footprint.

LGT Capital Partners is a global alternative investment manager focused on private markets and multi-asset solutions. Founded in the late 1990s and affiliated with LGT Group, the firm is headquartered in Switzerland with offices in major financial centers worldwide. It provides investment programs across private equity, private credit, hedge funds, real estate, and related multi-asset strategies, serving institutional clients such as pension funds, sovereign wealth funds, insurance companies, foundations, and banks. The firm emphasizes manager selection, diversification, and co-investment opportunities, and employs a range of strategies including long/short equity, event-driven, and global macro approaches. As part of its offering, LGT Capital Partners pursues primary fund commitments, secondaries, and direct investments through specialized mandates, aiming to align interests with clients and deliver long-term, risk-adjusted returns.

TeleSoft Partners is a venture capital investment firm founded in 1996 and based in Aspen, Colorado. It provides value-added capital and strategic support to technology, energy, and related sectors across the United States, helping entrepreneurs grow early-, mid-, and late-stage companies. The firm emphasizes leveraging its knowledge, contacts, and experience to accelerate growth and exits, and has participated in the development of more than 75 companies, with over 50 acquisitions or public offerings.

Paradigm is a San Francisco-based investment firm focused on crypto and frontier technology. A research-driven organization, it identifies and backs category-defining protocols and technology companies, collaborating with founders to build and scale innovative projects that reshape how people transact, build, and compute. Founded in 2018, the firm makes investments across stages and geographies and maintains offices in San Francisco, New York, and Washington, D.C.

Section 32 is a venture capital investment firm founded in 2017 by Bill Maris, based in Silicon Valley, California. It targets early-stage investments in life science, healthcare, and technology companies across the United States, supporting ventures in artificial intelligence, software, data, enterprise software, cybersecurity, fintech, quantum computing, computational biology, biotechnology, and related sectors. The firm aims to accelerate the discovery, development, and distribution of revolutionary technologies that improve the human condition and has a notable portfolio with exits across biotechnology, AI, and healthcare.

Nauta Capital is a pan-European venture capital firm backing early-stage B2B software companies. Headquartered in London with offices in Barcelona and Munich, it operates across Europe and targets Series A to late seed and Series B investments in technology ventures. The firm focuses on B2B software with strong network effects, vertically oriented enterprise tech for large industries, and deep-tech applications that address enterprise challenges, including sectors such as retail tech, revenue tech, fintech, insurtech, health tech, enterprise software, developer tools, infrastructure, AI and ML, and security and privacy. With more than half a billion in assets under management and a team of around 20 professionals, Nauta is regarded as one of Europe’s larger B2B-focused investors.

Athos Capital is a venture capital investment firm headquartered in Madrid, Spain, founded in 2016. It backs early-stage technology companies across Europe, with a focus on Spain. The firm's target sectors include cloud-based farm management software, storage solutions, Internet of Things, corporate accommodation platforms, and financial and educational technology.

Maverick Ventures is the venture capital arm of Maverick Capital, a San Francisco-based global investment firm. It combines the resources of a large, diversified firm with an agile, focused team to support entrepreneurs from seed through growth stages. With more than 30 years of early-stage investing experience, Maverick Ventures has funded numerous companies in healthcare, software, and deep technology, and its team typically leads rounds, takes board seats, and collaborates with management to build successful enterprises.

Ecosystem Ventures is a venture capital firm and strategic consulting company that backs seed-stage technology startups and provides advisory services. Established in 2005 and based in San Francisco, the firm supports entrepreneurs through early funding and strategic guidance toward a Series A, with consulting and investment activities spanning the American, Indian, and European markets.

Norwest is a venture capital and growth equity investment firm that focuses on venture and growth-stage companies. Since its inception, it has invested in more than 600 companies and partnered with over 140 active companies across its venture and growth equity portfolio. The firm backs early to late-stage companies across sectors with a focus on consumer, enterprise, and healthcare, and it provides a deep network of connections, operating experience, and a broad range of services to help CEOs and founders scale their businesses.

123 Investment Managers is an independent investment firm based in Paris with offices in Lyon, specializing in private asset investments across venture capital, private equity, and fund of funds. It pursues direct investments in a broad range of stages from seed to mature growth and co-investment opportunities, primarily in technology, industry, renewable energy, and consumer sectors, and also in health-related and eldercare services, hotels, clinics, and other accommodation ventures. The firm focuses on Europe, with emphasis on France, Switzerland, the United States, and Canada, and targets portfolio company enterprise values roughly €5 million to €400 million, investing typically from about €0.8 million to €8 million per deal. It also offers multi-theme private asset strategies across tourism, healthcare, infrastructure, and real estate to help private and institutional clients access unlisted French companies and long-term value creation.

TPY Capital is a Tel Aviv-based venture capital firm that focuses on early-stage and growth technology investments in Israeli companies. The firm typically leads rounds and concentrates on sectors such as data and analytics, digitization and human augmentation, fintech, cloud infrastructure, enterprise software, and frontier technologies including quantum computing and machine learning. It pursues minority equity positions and has a track record of backing technology startups across pre-revenue and revenue-stage growth. Founded in 2011, TPY Capital selects opportunities within the Israeli tech ecosystem and seeks to support companies pursuing enterprise productivity, data-driven solutions and digital transformation.

ProQuest Investments is a healthcare venture capital firm founded in 1998 that provides seed to late-stage financing to healthcare and biotechnology companies. The firm manages over $875 million in capital and operates offices in Princeton, San Diego, and Montreal. It has a focus on therapeutics and has investments across oncology, pain, and infectious disease, seeking long-term partnerships with entrepreneurs.